I. Introduction
In Korea, the number of cases of bisphosphonate-related osteonecrosis of the jaw (BRONJ) occurring in female patients as a result of dental treatment following medication for postmenopausal osteoporosis has been recently increasing 1 . The American Association of Oral and Maxillofacial Surgeons (AAOMS) define BRONJ as medication-related osteonecrosis of the jaw in cases where antiresorptive or antiangiogenic agents have been administered, continuous bone exposure in the maxillofacial area for a period of more than eight weeks has been confirmed, and radiation therapy of the maxillofacial area has not been performed 2 . The AAOMS also describe treatment methods according to the classifications determined by the patient's symptoms 2 . Although
Upon a radiologic study, we found sequestrum formation in the #16 area, which had a well-defined margin, making it easily distinguishable 4 . The region extended beyond the alveolar bone into the right maxillary sinus (Fig. 2) , and a bone scan image showed increased intake in the right maxillary area. (Fig. 3) Because there was an exposed bone lesion that extended to the right maxillary sinus, the patient was diagnosed with stage 3 BRONJ according to the AAOMS classification criteria 2 , and conservative treatment was primarily given. The laboratory tests showed carboxy-terminal collagen crosslinks (CTX) in serum 0.174 ng/mL, vitamin D 11.9 ng/ mL (reference value, 30.1-100.0 ng/mL), and serum osteocalcin 1.4 ng/mL (reference value, 5-25 ng/mL). After an endocrinology consult, it was confirmed that surgical intervention would be possible and vitamin D (0.5 μg, once a day, Onealfa Tab.; Ilsung Pharmaceuticals, Seoul, Korea) was prescribed. . In radiologic study, the sequestrum formation was seen on #16 area with welldefined margin extended beyond the alveolar bone reaching to the right maxillary sinus. The CBCT images show increased haziness on the right maxillary sinus. bone margin and an uneventfully healed maxilla. (Fig. 7) 
III. Discussion
Underlying diseases related to BRONJ include primarily malignant tumors, multiple myeloma and osteoporosis 3 . In this case, the patient's past medical history was significant for malignancy and osteoporosis, although osteoporosis was the primary indication for bisphosphonate treatment. BRONJ is more common in females because menopause is the main etiology of osteoporosis. The male-to-female incidence ratio of BRONJ is about 4:6, regardless of the underlying diseases 5, 6 . In our research from 2007 to 2014, there were 11 male and 213 female BRONJ patients. In accordance After admission, intravenous antibiotics (four times a day, Fullgram Injection 300 mg; Samjin Pharm, Seoul, Korea) were given. We performed a surgical operation including sequestrum resection, partial maxillectomy, and extraction of the first and second premolars. The defect area was covered with a buccal fat pad flap. (Fig. 4) In order to relieve sinus symptoms, mucolytics and nasal decongestants were administered for two weeks following surgery.
Biopsy results confirmed actinomycotic osteomyelitis 4 . (Fig.  5) Postoperative healing was uneventful. After discharge, regular follow-up visits were conducted. There were no signs of recurrence and a clean and fully healed mucosa was observed in the intraoral picture taken sixty days postoperatively. (Fig. 6) The postoperative X-ray showed a clearly resected 
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of BRONJ. Osteoporosis in males tends to be overlooked or underestimated compared with females. Only 10% of male patients receive treatment for osteoporosis due to lack of awareness 8 , and the incidence of osteoporosis tends to increase more significantly in males over 70 years of age compared with females 7 . Cases of BRONJ affecting the maxilla are rarer than those in the mandible 9 . However, in the case of advanced maxillary lesions, sinusitis or intracranial complications can occur 10, 11 . As most of these patients are elderly and many have a history of variable diseases, they require prompt treatment.
In many BRONJ cases, infections and recurrence may occur; in other words, the healing process is often compromised for many reasons. Because of impaired vascularity, the healing alveolus may be vulnerable to bacterial infections. In order to reduce exposure to bacterial infections, primary closure is important 12 . We performed a sequestrectomy and partial with this, a medical history including osteoporosis is likely to be overlooked more frequently in male patients before dental treatment. In this case, osteoporosis developed as a result of aging and hypogonadism after receiving an orchiectomy and the patient was treated with alendronate (Fosamax Tab. 70 mg) for about four years. In this condition, bone turnover activity is suppressed and the tooth extraction was performed indiscriminately. We conclude that BRONJ might have developed through this serial pathway. Osteoporosis in males can occur due to a variety of reasons, such as old age, steroid abuse, alcoholism and hypogonadism 7 . Among these, hypogonadism is a commonly occurring consequence associated with orchiectomy 7 . Because complications such as pelvic fracture may frequently occur with hypogonadism, bisphosphonate therapy is necessary for this group of patients. When a dentist first meets these patients, a careful medical history is required as there is a risk A B . In this case, after successful primary closure with local mucosa and the buccal fat pad flap, the wound healed uneventfully.
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